Logo image
Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor
Journal article   Open access   Peer reviewed

Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor

Joseph Pontillo, Joseph A. Tran, Beth A. Fleck, Dragan Marinkovic, Melissa Arellano, Fabio C. Tucci, Marion Lanier, Jodie Nelson, Jessica Parker, John Saunders, …
Bioorganic & medicinal chemistry letters, v 14(22), pp 5605-5609
15 Nov 2004
PMID: 15482933
url
https://doi.org/10.7270/q2db82k8View
Open

Abstract

Antagonist MC4 Melanocortin Piperazinebenzylamine
[Display omitted] SAR studies of a series of piperazinebenzylamines resulted in the discovery of potent antagonists of the human melanocortin-4 receptor. Compounds 11c, 11d, and 11l, which had K i values of 21, 14, and 15 nM, respectively, possessed low efficacy in cAMP stimulation (∼15% of α-MSH maximal level) mediated by MC4R, and functioned as antagonists in inhibition of α-MSH-stimulated cAMP release in a dose-dependent manner ( 11l, IC 50 = 36 nM).

Metrics

5 Record Views
33 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#2 Zero Hunger
#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Chemistry, Medicinal
Chemistry, Organic
Logo image